News in Brief

EC bestows novel food status on herb blend for supplement use

By Will Chu

- Last updated on GMT

©iStock
©iStock
The European Commission (EC) has given the go ahead for a blend of three herbal roots to be used as a novel food in a supplement intended for post-menopausal women.

After consultations with the European Food Safety Authority (EFSA), the EC concluded that an extract of these three herbal roots was safe for adults when added to food supplements at a maximum daily dose of 175 milligrams (mg).

“Taking into account the intended use and the request for authorisation is only intended for adults, food supplements containing an extract of three herbal roots (Cynanchum wilfordii Hemsley, Phlomis umbrosa Turcz. and Angelica gigas Nakai) should be appropriately labelled,”​ the ruling instructed.

EFSA had previously concluded that the risk of allergic reaction to Angelica gigas​ Nakai was “not dissimilar to that associated with celery as both plants belong to the same botanical family (i.e. Apiaceae)”.

As celery is a food required to be labelled as an allergen under Regulation (EU) No 1169/2011 of the European Parliament and of the Council (6), the EC instructed that labelling must be “in close proximity to the list of ingredients indicating that it should not be consumed by individuals with known celery allergy”.

Naturalendo Tech application

The EC’s decision brings a successful end to Naturalendo Tech’s application and means the company’s ingredients shall be included in the Union list of authorised novel foods as provided for in Article 8 of Regulation (EU) 2015/2283.

On its website, it describes it’s product Estro-G100, as a herbal root extract that claims to relieve 10 out of 12 most common menopausal symptoms including hot flashes, night sweats, trouble sleeping, nervousness, depression, dizziness and joint and muscle pain.

Naturalendo Tech first made its request back in March 2014 for the extract to be placed on the market as a novel food ingredient.

In July of that year, Irish authorities issued its initial assessment report, in which it concluded that an extract of mixture of the three herbal roots met the criteria for novel food ingredients set out in Article 3(1) of Regulation (EC) No 258/97.

EFSA adopted ‘Scientific opinion on the safety of an extract of three herbal roots (Cynanchum wilfordii Hemsley, Phlomis umbrosa Turcz. and Angelica gigas Nakai) as a novel food’ in September 2016.

The food authority reviewed its opinion in April 2017, where it reconfirmed the maximum daily dose of 175 mg as safe for adults.

Related news

Show more

Related products

show more

Searching for a High-Purity Low-Dose Ceramide?

Searching for a High-Purity Low-Dose Ceramide?

Content provided by Maypro | 28-Oct-2024 | Infographic

Ceramides are naturally occurring lipids that enable water retention and healthy functioning of the epidermal layers. As we age, the skin loses ceramides...

Unlock sensory innovation with AromatiQ™ technology

Unlock sensory innovation with AromatiQ™ technology

Content provided by Lonza | 20-Sep-2024 | Product Brochure

With 70% of consumers willing to pay a premium for a more enjoyable and memorable supplement experience, Lonza’s new AromatiQ™ technology enables brands...

From Biofarma a clinically tested vaginal protection

From Biofarma a clinically tested vaginal protection

Content provided by Biofarma Group | 05-Sep-2024 | Product Brochure

Bacterial vaginosis is considered the most common cause of vaginal infection among pregnant and non-pregnant women. In this scenario, the oral intake of...

Related suppliers

Follow us

Products

View more

Webinars